ACT

September 4/2018


Advertisement

news roundup

TrialAssure Partners with Otsuka Pharmaceutical

TrialAssure, a global company focused on developing clinical trial transparency tools, announced that it will partner with Otsuka Pharmaceutical Development and Commercialization, Inc. to implement its comprehensive transparency management system for all compounds in Otsuka's drug development pipeline.

Advertisement

Challenging the Status Quo: The Diffusion of Technology in Study Startup
Tuesday, September 25, 2018 at 1pm EDT | 12pm CDT | 10am PDT
Register Now


Scientific Advances Require Innovative Clinical Research Models

FDA is testing various strategies to streamline research and regulatory oversight by looking to novel clinical trial designs to advance new treatments.


Advertisement

A Next Generation Sequencing Approach to Influenza Vaccine Development
Thursday, September 20, 2018 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Register Now


CROs To See 12% Yearly Growth to 2021

New report forecasts the global market for clinical trial services to biopharma companies to jump 12% year-on-year to 2021.


Advertisement

Decoding the Distinction: DMCs, CECs, and Their Role in Medical Device Research
Wednesday, September 12, 2018 at 11am EDT | 10am CDT | 4pm BST | 5pm CEST
Register Now


Does The EU Really Care About Health Policy?

Recent developments offer more clues to the EU's seemingly less-than-serious approach to health policy formation.


Advertisement

In this edition

CROs To See 12% Yearly Growth to 2021
BlockChain in Clinical Trials—the Ultimate Data Notary
The Importance of Age Diversity in Clinical Trials


Events

American Pharma Outsourcing Summit
Basket and Umbrella Trials for Oncology
Crossroads: An Artia Solutions Conference
Search Upcoming Events

Subscribe

Subscribe

Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers »


Articles

New ICH Guidelines Address Industry Inefficiency

In this article, Crissy MacDonald reviews the key changes in ICH E6 (R2), discuss the challenges organizations are facing, and present actionable recommendations for organizations to implement now.


BlockChain in Clinical Trials—the Ultimate Data Notary

Assessing the benefits of using blockchain technology as a notary service in the network sharing of clinical data.

Blog Posts

The Importance of Age Diversity in Clinical Trials

Age diversity in clinical trials benefits both the patient experience and the success of the trial.


A Guide to Avoiding the Common Pitfalls of Market Landscaping

Comprehensive market landscaping includes disparate data sets from primary and secondary sources and is a time-consuming process that requires domain expertise and commitment.


Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription

Get the full picture


Ask the editor

Lisa Henderson
Editor in Chief
Lisa.Henderson@ubm.com

Advertise

Todd Baker
Group Publisher
todd.baker@ubm.com